Brain Tumor News!


Note: The comments under each article title are the opinion of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!
Displaying Stories 6351 to 6370 of 7,617
Previous 20           Next 20


10/16/01 Research Highlights Comprehensive Cancer Care Conference 2001 October 19-21 (PR Newswire)
... dollars studying promising synthetic drugs to block the growth of blood vessels that feed tumors, many natural agents have anti-angiogenic properties....... botanicals and other natural compounds. 3:30 - 5 p.m., Potomac 1-2 Nutritional Treatment for Brain Cancer: Best Case Series (repeated Sunday, October 21, 11:30 a.m....... to improve the efficacy of conventional treatments and significantly prolong life for brain tumor patients....
       


10/16/01 DNA Repair Defect May Lead to Brain Tumor (Reuters)
Researchers have discovered a defect in the body's natural DNA repair mechanisms that may cause a deadly form of brain tumor called malignant glioma.
       


10/16/01 American Shared Hospital Services Third Quarter Sales Rise 20.3%, Operating Income Increases 29.3% (Business Wire)
...The Gamma Knife is the gold standard in non-invasive radiosurgery for brain tumors, vascular malformations and trigeminal neuralgia, commonly called facial pain....
       


10/15/01 The Latest Advances in Pathology to be Highlighted at Philadelphia Meeting (PR Newswire)
...-- Surgical Pathology of Benign and Malignant Tumors of Bone -......-- Commonly Encountered Brain Tumors -...
       


10/11/01 VSM MedTech Announces $4.3 Million Sale To NIH Upheld; U.S. General Accounting Office Denies Protest (CCN Newswire)
... develops and manufactures proprietary technology for MEG, which gives precise information on the brain's function including touch, speech, vision, hearing and motor skills.......This technology is approved for use in pre-surgical assessment of tumors, epilepsy tissue and localization of trauma, cognitive and psychological disorders....
       


10/11/01 Oncolytics Biotech Inc. Announces Approval to Proceed with Clinical Trial to Evaluate REOLYSIN(R) for the Treatment of Prostate Cancer (PR Newswire)
...As a secondary endpoint, the Company is measuring tumor response at both the treated lesion as well as remote metastatic sites....... cancer cells derived from many types of cancer including breast, prostate, pancreatic and brain tumours....
       


10/11/01 Oncolytics Biotech Inc. Announces Approval to Proceed with Clinical Trial to Evaluate REOLYSIN(R) for the Treatment of Prostate Cancer (Canada NewsWire)
...As a secondary endpoint, the Company is measuring tumor response at both the treated lesion as well as remote metastatic sites....... cancer cells derived from many types of cancer including breast, prostate, pancreatic and brain tumours....
       


10/11/01 Bio-Logic Systems Reports Results for Fiscal 2002 Second Quarter (PR Newswire)
... typically used by medical practitioners to aid in the diagnosis of certain neurological disorders, brain disorders and tumors, and sensory disorders, including audiological and hearing screening and...
       


10/11/01 American Shared Announces Conference Call to Discuss Third Quarter Results On October 16 At 2:30 PM Eastern (Business Wire)
...-- a non-invasive treatment of malignant and benign brain tumors, vascular malformations and trigeminal neuralgia facial pain....
       


10/11/01 New Family of Ten Cancer Related Genes Is Discovered By Researchers at The National Cancer Institute, The University of Texas' Southwestern Medical Center and M. D. Anderson Cancer Center (PR Newswire)
...Discovery of these tumor suppressor genes represents a joint collaborative effort by scientists at The University of...... have been incorporated into gene delivery systems and have blocked the growth of established tumors in animal models of lung cancer....... trials for INGN 201 in additional cancer indications including prostate, ovarian, bladder, brain, and breast cancer....
       


10/10/01 Franzen Up for National Book Award (AP)
... 52 years old and a resident of Amherst, Mass., has had several operations for a brain tumor and has failing eyesight....
       


10/10/01 Peregrine gets fast-track for brain cancer drug (Reuters Securities)
Drug developer Peregrine Pharmaceuticals Inc. on Wednesday said the U.S. Food and Drug Administration granted the company's experimental brain cancer drug an expedited review process if it is submitted for approval.
       


10/10/01 FDA Grants Peregrine Pharmaceuticals Fast Track Review Status For Cotara in Brain Cancer (Business Wire)
...Cotara is Peregrine's Tumor Necrosis Therapy (TNT) drug.......It is a radiolabeled monoclonal antibody that binds to the necrotic core of tumors and uses beta-radiation to kill the tumors from the inside out.......Cotara is currently being studied in a multi-center Phase II study for brain cancer....
       


10/10/01 Neurocrine Biosciences Invites You to Join Its Company Presentation at The UBS Warburg Global Life Sciences Conference Live on Thursday, October 11, 2001 (PR Newswire)
... largest pharmaceutical markets in the world including insomnia, anxiety, depression, malignant brain tumors and peripheral cancers, diabetes, multiple sclerosis,...
       


10/10/01 Introgen to Present at UBS Warburg Annual Healthcare Conference (PR Newswire)
... trials for INGN 201 in additional cancer indications including prostate, ovarian, bladder, brain, and breast cancer.......Introgen's second product candidate, INGN 241 (Adenoviral-mda7) for the treatment of solid tumors, is in Phase I clinical development....
       


10/10/01 Peregrine gets fast-track for brain cancer drug (Reuters Securities)
Drug developer Peregrine Pharmaceuticals Inc. on Wednesday said the U.S. Food and Drug Administration will give the company's antibody-based brain cancer drug an expedited review if it is submitted for approval.
       


10/09/01 Michael Rupert Needs 'A New Brain' in DC (Playbill)
Tony Award-winner Michael Rupert will play the ailing Gordon Schwinn in the Washington, DC, Studio Theatre's staging of A New Brain, the unique William Finn-James Lapine musical that explores a songwriter's emotional troubles when he is diagnosed with an apparent brain tumor.
       


10/09/01 Introgen's Vice President James Merritt Talks to 'Current Drug Discovery' About Progress With INGN 201 (PR Newswire)
... trials for INGN 201 in additional cancer indications including prostate, ovarian, bladder, brain, and breast cancer.......Introgen's second product candidate, INGN 241 (Adenoviral-mda7) for the treatment of solid tumors, is in Phase I clinical development....
       


10/08/01 AMDL Acquires Combination Immunogene Therapy Technology for the Eradication of Human Tumors (Business Wire)
...The GM-CSF gene enters the patient's tumor and genetically alters the tumor so that it attracts the patient's antigen presenting cells...... proved 100 percent effective in eradicating experimental human brain tumors implanted in mice," said Gary L. Dreher, AMDL president and CEO....
       


10/08/01 American, 2 Brits Win Medicine Prize (AP)
...Research into the cell cycle field is about to be applied to diagnosing tumors and may eventually open new doors for therapy, the committee said. Members of the prize committee...... Arvid Carlsson of Sweden and Americans Paul Greengard and Eric Kandel for research on how brain cells transmit signals to each other, thus increasing understanding on how the brain functions...
       


Displaying Stories 6351 to 6370 of 7617
Previous 20           Next 20


Our privacy / cookie policy has changed.
Click HERE to read it!